Insider · CIK 0001131146

DAVIS STEPHEN

Reports to the SEC for 7 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001131146

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-19	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−31.7K sh	$15.28	−$485K	186,555
2024-08-16	ACADACADIA PHARMACEUTICALS INCA Award	Director, CEO	AAward	+17.3K sh	—	—	173,520
2024-08-16	ACADACADIA PHARMACEUTICALS INCA Award	Director, CEO	AAward	+44.8K sh	—	—	218,302
2024-05-02	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−11.4K sh	$16.94	−$194K	155,231
2024-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−22.4K sh	—	—	67,173
2024-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+22.4K sh	—	—	166,658
2024-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−17.7K sh	$17.87	−$317K	144,267
2024-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−8,858 sh	$17.87	−$158K	161,983
2024-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−34.7K sh	—	—	138,666
2024-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−17.3K sh	—	—	34,667
2024-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+17.3K sh	—	—	136,175
2024-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+34.7K sh	—	—	170,841
2024-03-27	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−17.7K sh	$17.90	−$317K	118,842
2024-03-25	ACADACADIA PHARMACEUTICALS INCA Award	Director, CEO	AAward	+34.7K sh	—	—	136,556
2024-03-25	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+286K sh	—	—	286,451
2024-02-26	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−5,577 sh	$24.67	−$138K	101,890
2024-02-23	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+10.9K sh	—	—	107,467
2024-02-23	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−10.9K sh	—	—	10,946
2024-01-08	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−3,732 sh	$29.96	−$112K	96,521
2024-01-06	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+9,528 sh	—	—	100,253
2024-01-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−9,528 sh	—	—	0
2023-10-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−104K sh	—	—	173,332
2023-10-06	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−51.6K sh	$21.96	−$1.13M	89,131
2023-10-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+104K sh	—	—	140,694
2023-07-14	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+100K sh	$20.77	+$2.08M	136,695
2023-07-14	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−100K sh	—	—	220,000
2023-07-14	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−100K sh	$30.04	−$3M	36,695
2023-07-12	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−55.1K sh	$25.05	−$1.38M	36,695
2023-07-11	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−16.5K sh	$25.00	−$412K	91,799
2023-05-01	ACADACADIA PHARMACEUTICALS INC · Stock Options (Right to Buy)A Award	Director, CEO	AAward	+296K sh	—	—	295,503
2023-05-01	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−7,806 sh	$21.18	−$165K	108,297
2023-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director, CEO	AAward	+89.6K sh	—	—	89,564
2023-04-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−15.6K sh	—	—	0
2023-04-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+15.6K sh	—	—	116,103
2023-04-06	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−8,582 sh	$18.16	−$156K	100,478
2023-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−17.3K sh	—	—	52,000
2023-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+17.3K sh	—	—	109,060
2023-02-24	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−3,851 sh	$18.78	−$72.3K	91,727
2023-02-23	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−10.9K sh	—	—	21,892
2023-02-23	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+10.9K sh	—	—	95,578
2023-01-09	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−3,904 sh	$17.13	−$66.9K	84,633
2023-01-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−9,528 sh	—	—	9,528
2023-01-06	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+9,528 sh	—	—	88,537
2023-01-03	BELLICUM PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+74.7K sh	—	—	136,854
2022-12-16	HRTXHERON THERAPEUTICS, INC. /DE/A Award	Director	AAward	+38.6K sh	—	—	52,032
2022-12-16	HRTXHERON THERAPEUTICS, INC. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+77.2K sh	—	—	77,160
2022-10-15	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−5,938 sh	—	—	0
2022-10-15	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director, CEO	MExercise/Conversion	+5,938 sh	—	—	81,813
2022-10-15	ACADACADIA PHARMACEUTICALS INCS Sale	Director, CEO	SSale	−2,804 sh	$15.81	−$44.3K	79,009
2022-09-01	BELLICUM PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+43.4K sh	—	—	62,115

Recent filings

Accepted (ET)
Aug 204
DAVIS STEPHEN0001415889-24-021724
SEC(opens sec.gov)
May 34
DAVIS STEPHEN0001415889-24-012238
SEC(opens sec.gov)
Apr 94
DAVIS STEPHEN0001415889-24-010604
SEC(opens sec.gov)
Mar 274
DAVIS STEPHEN0001415889-24-009271
SEC(opens sec.gov)
Feb 274
DAVIS STEPHEN0001415889-24-005572
SEC(opens sec.gov)
Jan 94
DAVIS STEPHEN0001209191-24-001269
SEC(opens sec.gov)

Companies

Address

TRIMERIS, INC 2530 MERIDIAN PKWY, 2ND FLOOR

DURHAM, NC, 27713